{"id":9449,"date":"2020-12-09T09:11:28","date_gmt":"2020-12-09T08:11:28","guid":{"rendered":"https:\/\/ggba.swiss\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/"},"modified":"2023-07-04T13:43:30","modified_gmt":"2023-07-04T11:43:30","slug":"lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/","title":{"rendered":"L\u2019entreprise medtech vaudoise Abionic lance le premier test de s\u00e9v\u00e9rit\u00e9 Covid-19 pour faciliter le triage des patients"},"content":{"rendered":"

Avec le lancement de son dispositif cSOFA homologu\u00e9 CE, qui \u00e9value la gravit\u00e9 du Covid-19 chez les patients dans les cinq minutes suivant l’analyse d’un \u00e9chantillon de sang, Abionic vise \u00e0 pr\u00e9venir la surcharge des h\u00f4pitaux en permettant ainsi un meilleur triage et affectation des patients.<\/h4>\n

Depuis le d\u00e9but de la pand\u00e9mie du Covid-19, les pays du monde entier ont connu des taux d’occupation croissants dans les h\u00f4pitaux. Jusqu’\u00e0 pr\u00e9sent, le triage des patients reposait principalement sur l’\u00e2ge du patient, un crit\u00e8re parfois critiqu\u00e9 comme \u00e9tant discriminatoire.<\/p>\n

La start-up vaudoise et spin-off de l’EPFL<\/a>, Abionic<\/a>, a lanc\u00e9 le score cSOFA (Covid Sequential Organ Failure Assessment), qui permet de passer de crit\u00e8res d\u00e9mographiques \u00e0 des crit\u00e8res m\u00e9dicaux, en tenant compte de la gravit\u00e9 de chaque cas. En seulement cinq minutes, l’outil fournira les r\u00e9sultats qui serviront de base pour r\u00e9partir les patients atteints de Covid-19 dans les h\u00f4pituax.<\/p>\n

Le score cSOFA a obtenu le marquage CE et repose sur la PSP (Pancreatic Stone Protein), un nouveau biomarqueur qu’Abionic a d\u00e9j\u00e0 valid\u00e9 cliniquement et commercialise actuellement.<\/p>\n

Des nanotechnologies de pointe pour des dispositifs polyvalents<\/h4>\n

Fond\u00e9e en 2010 et install\u00e9e au Biop\u00f4le<\/a>, Abionic est une soci\u00e9t\u00e9 medtech qui commercialise une technologie nanofluidique r\u00e9volutionnaire, fournissant aux professionnels de la sant\u00e9 un outil de diagnostic rapide, simple et universel. La nanotechnologie de pointe d\u2019Abionic am\u00e9liore l\u2019efficacit\u00e9 et la polyvalence des tests ELISA standards afin d\u2019offrir des options de traitement au point de service (POC) optimales, avec la possibilit\u00e9 de r\u00e9duire les techniques biologiques actuelles de la macro-\u00e9chelle \u00e0 la nano-\u00e9chelle dans un environnement multi-analytique.<\/p>\n

La plateforme de diagnostic in vitro (IVD) d\u2019Abionic fournit des r\u00e9sultats de qualit\u00e9 laboratoire en 5 minutes \u00e0 partir d\u2019une seule goutte de sang, permettant un diagnostic personnalis\u00e9 et la possibilit\u00e9 de commencer imm\u00e9diatement un traitement.<\/p>\n","protected":false},"excerpt":{"rendered":"

Avec le lancement de son dispositif cSOFA homologu\u00e9 CE, qui \u00e9value la gravit\u00e9 du Covid-19 chez les patients dans les cinq minutes suivant l’analyse d’un \u00e9chantillon de sang, Abionic vise \u00e0 pr\u00e9venir la surcharge des h\u00f4pitaux en permettant ainsi un meilleur triage et affectation des patients. Depuis le d\u00e9but de la pand\u00e9mie du Covid-19, les […]<\/p>\n","protected":false},"author":3,"featured_media":9450,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1027,1060],"class_list":["post-9449","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-covid-19-fr","tag-medtech-fr"],"acf":[],"yoast_head":"\nL\u2019entreprise medtech vaudoise Abionic lance le premier test de s\u00e9v\u00e9rit\u00e9 Covid-19 pour faciliter le triage des patients - Greater Geneva Bern area<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L\u2019entreprise medtech vaudoise Abionic lance le premier test de s\u00e9v\u00e9rit\u00e9 Covid-19 pour faciliter le triage des patients - Greater Geneva Bern area\" \/>\n<meta property=\"og:description\" content=\"Avec le lancement de son dispositif cSOFA homologu\u00e9 CE, qui \u00e9value la gravit\u00e9 du Covid-19 chez les patients dans les cinq minutes suivant l’analyse d’un \u00e9chantillon de sang, Abionic vise \u00e0 pr\u00e9venir la surcharge des h\u00f4pitaux en permettant ainsi un meilleur triage et affectation des patients. Depuis le d\u00e9but de la pand\u00e9mie du Covid-19, les […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-09T08:11:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-04T11:43:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Abionic-630x380-3.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"630\" \/>\n\t<meta property=\"og:image:height\" content=\"380\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mathieu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"mathieu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/\"},\"author\":{\"name\":\"mathieu\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"headline\":\"L\u2019entreprise medtech vaudoise Abionic lance le premier test de s\u00e9v\u00e9rit\u00e9 Covid-19 pour faciliter le triage des patients\",\"datePublished\":\"2020-12-09T08:11:28+00:00\",\"dateModified\":\"2023-07-04T11:43:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/\"},\"wordCount\":347,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Abionic-630x380-3.jpeg\",\"keywords\":[\"Covid-19\",\"Medtech\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/\",\"name\":\"L\u2019entreprise medtech vaudoise Abionic lance le premier test de s\u00e9v\u00e9rit\u00e9 Covid-19 pour faciliter le triage des patients - Greater Geneva Bern area\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Abionic-630x380-3.jpeg\",\"datePublished\":\"2020-12-09T08:11:28+00:00\",\"dateModified\":\"2023-07-04T11:43:30+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\"},\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Abionic-630x380-3.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Abionic-630x380-3.jpeg\",\"width\":630,\"height\":380},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L\u2019entreprise medtech vaudoise Abionic lance le premier test de s\u00e9v\u00e9rit\u00e9 Covid-19 pour faciliter le triage des patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab\",\"name\":\"mathieu\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/mathieu\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L\u2019entreprise medtech vaudoise Abionic lance le premier test de s\u00e9v\u00e9rit\u00e9 Covid-19 pour faciliter le triage des patients - Greater Geneva Bern area","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/","og_locale":"fr_FR","og_type":"article","og_title":"L\u2019entreprise medtech vaudoise Abionic lance le premier test de s\u00e9v\u00e9rit\u00e9 Covid-19 pour faciliter le triage des patients - Greater Geneva Bern area","og_description":"Avec le lancement de son dispositif cSOFA homologu\u00e9 CE, qui \u00e9value la gravit\u00e9 du Covid-19 chez les patients dans les cinq minutes suivant l’analyse d’un \u00e9chantillon de sang, Abionic vise \u00e0 pr\u00e9venir la surcharge des h\u00f4pitaux en permettant ainsi un meilleur triage et affectation des patients. Depuis le d\u00e9but de la pand\u00e9mie du Covid-19, les […]","og_url":"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2020-12-09T08:11:28+00:00","article_modified_time":"2023-07-04T11:43:30+00:00","og_image":[{"width":630,"height":380,"url":"https:\/\/staging.ggba.swiss\/app\/uploads\/2023\/06\/Abionic-630x380-3.jpeg","type":"image\/jpeg"}],"author":"mathieu","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"mathieu","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/"},"author":{"name":"mathieu","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"headline":"L\u2019entreprise medtech vaudoise Abionic lance le premier test de s\u00e9v\u00e9rit\u00e9 Covid-19 pour faciliter le triage des patients","datePublished":"2020-12-09T08:11:28+00:00","dateModified":"2023-07-04T11:43:30+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/"},"wordCount":347,"image":{"@id":"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Abionic-630x380-3.jpeg","keywords":["Covid-19","Medtech"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/","url":"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/","name":"L\u2019entreprise medtech vaudoise Abionic lance le premier test de s\u00e9v\u00e9rit\u00e9 Covid-19 pour faciliter le triage des patients - Greater Geneva Bern area","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Abionic-630x380-3.jpeg","datePublished":"2020-12-09T08:11:28+00:00","dateModified":"2023-07-04T11:43:30+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab"},"breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Abionic-630x380-3.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/06\/Abionic-630x380-3.jpeg","width":630,"height":380},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/lentreprise-medtech-vaudoise-abionic-lance-premier-test-de-severite-covid-19-faciliter-triage-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"L\u2019entreprise medtech vaudoise Abionic lance le premier test de s\u00e9v\u00e9rit\u00e9 Covid-19 pour faciliter le triage des patients"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/de091cdfd7d8bce46f9b8b1cf9d868ab","name":"mathieu","url":"https:\/\/ggba.swiss\/fr\/author\/mathieu\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/9449","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=9449"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/9449\/revisions"}],"predecessor-version":[{"id":17850,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/9449\/revisions\/17850"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/9450"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=9449"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=9449"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=9449"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}